APA (7th ed.) Citation

Roost, M. S., Potthast, H., Walther, C., García-Arieta, A., Abalos, I., Fernandes, E. A. F., . . . Braddy, A. (2021). Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Canadian Society for Pharmaceutical Sciences.

Chicago Style (17th ed.) Citation

Roost, Matthias Shona, et al. Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Canadian Society for Pharmaceutical Sciences, 2021.

MLA (8th ed.) Citation

Roost, Matthias Shona, et al. Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Canadian Society for Pharmaceutical Sciences, 2021.